Why Definium Therapeutics (DFTX) Is Up 49.8% After DT120 Phase 3 Win And $700 Million Raise

Earlier this week, Definium Therapeutics reported that its Phase 3 Emerge trial of DT120 ODT in major depressive disorder met its primary and all key secondary endpoints, showing rapid and durable ...

Triple-Agonist Retatrutide Mimics Bariatric Surgery in Phase 3 Trial

Topline Phase 3 TRIUMPH-1 trial results show retatrutide drives a 30.3 percent body weight loss over 104 weeks of treatment.

Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%

The company reported that the U.S. Food and Drug Administration aligned with the company on several key aspects of the Phase ...

Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

Definium shares soar after reporting positive phase 3 results for single-dose depression treatment

Definium Therapeutics Inc. DFTX shares are surging Monday after the company announced positive topline results from its Phase ...
BioSpace

Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial

Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to ...
The Manila Times

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has begun treating patients in RASolute 305, ...

The PWHL Officially Completes Phase 3 Of The Expansion Player Distribution Process

The league completes its third phase of expansion, in which each of the eight existing teams protects three additional ...